Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Diabetes 60 , 168176 (2011)
The North America GLP-1 receptor agonist market dominated the revenue with 75.46% share in 2025, supported by a high prevalence of metabolic disorders, early adoption of novel therapeutics, and a well-established healthcare infrastructure
Im optimistic on how the combination of an oral option plus market competition is going to mean access for more patients that want and would benefit from these medications
In practical terms, the label says we do not know
US$ 26.07
US$ 26.35
US$ 24.60
US$ 25.41
